ZIOPHARM Oncology Inc. | Key People and Executives
Scott L. Tarriff
Director
Murray F. Brennan
Lead Independent Non-Executive Director
James Anthony Cannon
Independent Director
Wyche Fowler
Independent Director
Laurence James Neil Cooper
Chief Executive Officer
David M. Mauney
Chief Operating & Business Officer, Executive VP
Kevin G. Lafond
Treasurer, Chief Accounting Officer & SVP-Finance
Francois Lebel
Chief Medical Officer, EVP-Research & Development
Lynn M. Ferrucci
SVP-Human Resources, Facilities & Administration
Scott L. Tarriff
Director
David Connolly
VP-Corporate Communications & Investor Relations
Murray F. Brennan
Lead Independent Non-Executive Director
James Anthony Cannon
Independent Director
Wyche Fowler
Independent Director
Address |
Parris Building Boston Massachusetts 02129 United States
|
Employees
|
- |
Website |
http://www.ziopharm.com |
Updated |
07/08/2019 |
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA. |